Internal Medicine, Infectious Disease · Morris, IL
NPI
1073666707
Since 2007
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
425 E US Route 6
Morris, IL, 60450
Phone (815) 513-3074
Groups this clinician bills Medicare through
Medicare paid, 2024
$59K
562 services
Medicare patients, 2024
171
Average age 74
Drug cost, 2024
$206K
654 prescriptions
Company payments, 2025
$53.83
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by John Bolden Jr. was code 99233 (hospital e&m - subsequent), 174 times for 57 patients. In total John Bolden Jr. billed 562 services in 13 codes, and Medicare paid $59K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-04-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 174 | 57 | $94.44 | $16K |
| 99214 Office E&M - Established | Office | 113 | 66 | $93.77 | $11K |
| 99223 Hospital E&M - Initial | Facility | 57 | 55 | $135.86 | $7,744 |
| 99215 Office E&M - Established | Office | 57 | 38 | $136.70 | $7,792 |
| 99232 Hospital E&M - Subsequent | Facility | 57 | 24 | $59.35 | $3,383 |
| 99204 Office E&M - New | Office | 27 | 27 | $122.53 | $3,308 |
| 99291 Critical Care E&M | Facility | 27 | 14 | $169.96 | $4,589 |
| 99205 Office E&M - New | Office | 20 | 20 | $169.07 | $3,381 |
| 99222 Hospital E&M - Initial | Facility | 17 | 16 | $104.49 | $1,776 |
By year: 2022 $60K for 599 services; 2023 $52K for 569 services; 2024 $59K for 562 services.
Medicare prescription drug claims, 2024
In 2024, the drug John Bolden Jr. prescribed most often to Medicare patients was Ceftriaxone (Ceftriaxone Sodium), with 63 prescriptions and refills. In total John Bolden Jr. wrote 654 Medicare prescriptions that cost $206K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ceftriaxone Ceftriaxone Sodium | 63 | 63 | Under 11 | $6,920 |
| Penicillin G Potassium Generic | 52 | 52 | Under 11 | $4,074 |
| Rifampin Generic | 52 | 53 | Under 11 | $15K |
| Rifadin Rifampin | 51 | 51 | Under 11 | $19K |
| Levofloxacin Generic | 37 | 39 | 26 | $265 |
| Magnesium Sulfate Generic | 36 | 36 | Under 11 | $692 |
| Fosfomycin Tromethamine Generic | 35 | 35 | Under 11 | $3,725 |
| Sodium Chloride 0.9 % Sodium Chloride | 32 | 32 | Under 11 | $1,457 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 32 | 49 | 18 | $254 |
| Daptomycin Generic | 30 | 30 | Under 11 | $25K |
| Cefuroxime Cefuroxime Axetil | 26 | 27 | 12 | $582 |
| Vancomycin Hcl Generic | 22 | 22 | 11 | $4,521 |
| Ciprofloxacin Hcl Generic | 20 | 26 | Under 11 | $117 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 20 | 20 | Under 11 | $282 |
| Fluconazole Generic | 19 | 25 | Under 11 | $663 |
Brand drugs: 164 claims; generic drugs: 490 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid John Bolden Jr. $53.83 ($53.83 in general payments such as food, travel and fees) from 2 companies. The largest payer was Melinta Therapeutics, LLC with $34.51.
| Company | Payments | Amount |
|---|---|---|
| Melinta Therapeutics, LLC | 2 | $34.51 |
| Abbvie Inc. ABBV | 1 | $19.32 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.